Bilateral ureteral obstruction due to Saccharomyces cerevisae fungus balls

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 636-637

  Senneville, Eric ^a,b   Ajana, Faïza ^a   Gérard, Yann ^a   Bourez, Jean Michel ^a   Alfandari, Serge ^a   Chidiac, Christian ^a   Mouton, Yves ^a  

^a UNIV LILLE   (France)

^b Hopital Dron   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; ITRACONAZOLE; PEFLOXACIN; PREDNISONE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; ECHOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYELOGRAPHY; SACCHAROMYCES CEREVISIAE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0029787631     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.636     Document Type: Article

References (5)

1. Irby PB, Stoller ML, McAnnich JW. Fungal bezoars of the upper urinary tract. J Urol 1990;143:447-51.
2. Eng R, Drehmel R, Smith SM, Goldstein EJC. Saccharomyces cerevisiae infections in man. Sabouraudia 1984;22:403-7.
3. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980;73:518-21.
4. McGinnis MR, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, suceptibility testing, and assays of activity in biological fluids. In: Lorian V, ed. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 1986:223-81.
5. Van Cutsem J, Van Gerven F, Janssen PAJ. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis 1987;9(suppl 1):S15-32.